DFRSX
Price
$17.26
Change
-$0.05 (-0.29%)
Updated
Jan 22 closing price
Net Assets
149.05M
FTCNX
Price
$66.57
Change
+$0.01 (+0.02%)
Updated
Jan 22 closing price
Net Assets
924.54M
Ad is loading...

DFRSX vs FTCNX

Header iconDFRSX vs FTCNX Comparison
Open Charts DFRSX vs FTCNXBanner chart's image
DFA Asia Pacific Small Company I
Price$17.26
Change-$0.05 (-0.29%)
VolumeN/A
Net Assets149.05M
Fidelity Advisor Canada M
Price$66.57
Change+$0.01 (+0.02%)
VolumeN/A
Net Assets924.54M
DFRSX vs FTCNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DFRSX vs. FTCNX commentary
Jan 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFRSX is a Hold and FTCNX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
FTCNX has more cash in the bank: 925M vs. DFRSX (149M). DFRSX pays higher dividends than FTCNX: DFRSX (4.60) vs FTCNX (0.74). DFRSX was incepted earlier than FTCNX: DFRSX (32 years) vs FTCNX (18 years). DFRSX (0) and FTCNX (0) have matching initial minimum investment requirements. DFRSX annual gain was more profitable for investors over the last year : 8.16 vs. FTCNX (5.21). FTCNX return over 5 years is better than : 29.18 vs. DFRSX (-3.26).
DFRSXFTCNXDFRSX / FTCNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence32 years18 years-
Gain YTD3.1682.101151%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets149M925M16%
Annual Yield % from dividends4.600.74626%
Returns for 1 year8.165.21157%
Returns for 3 years-12.647.61-166%
Returns for 5 years-3.2629.18-11%
Returns for 10 years15.4240.0239%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IDR12.270.35
+2.94%
Idaho Strategic Resources
SNX141.500.73
+0.52%
TD SYNNEX Corp
SKYT11.56-0.20
-1.70%
SkyWater Technology
MIRM46.72-1.26
-2.63%
Mirum Pharmaceuticals
PTPI0.31-0.01
-3.31%
Petros Pharmaceuticals